Inaktiver Wert

Andere Sprachen Zymeworks Inc. Toronto S.E.

Aktien

ZYME

CA98985W1023

ZYME

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)	16.05.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	07.05.
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results	02.05.
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results	02.05.
Zymeworks Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02.05.
Unlocking the potential of antibody drug conjugates	01.05.
Zymeworks Announces Participation in Upcoming Investor Conferences	30.04.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	28.04.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	20.04.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	12.04.
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024	11.04.
Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting	08.04.
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting	08.04.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME	05.04.
Zymeworks Inc. Removes Christopher Astle from the Positions of Chief Financial Officer	04.04.
Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President	04.04.
Zymeworks Inc. Announces the Composition of the Committees	28.03.
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors	28.03.
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024	28.03.
Zymeworks Announces Participation in Upcoming Investor Conferences	27.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zymeworks Inc. Toronto S.E.

Aktien

ZYME

CA98985W1023

ZYME

Andere Sprachen

Filter